Top Keywords: 2021, esmo, efficacy and safety, 2021 virtual, efficacy and, imbrave150, efficacy, exploratory, and safety, virtual, trials, influencers, conferences, safety, reserved, terms of service, of service, in patients with, all rights reserved, figures for, hepatocellular carcinoma, in patients, rights reserved, all rights, patients with, treated with, extrahepatic, macrovascular, atezolizumab, sorafenib, hepatocellular, ehs, bevacizumab, sor, mvi, carcinoma, Theres a total of 53 keywords.
StatisticsWe first found this page on 2023-03-23 22:16:01 +0000. It was last re-indexed on 2024-09-26 03:12:35 +0000 and with a fetch interval of 90 days it will be fetched again in 31 days on 2024-12-24 or soon thereafter. Last fetch returned code 200, OK, the current page state is ACTIVE. Traffic Data for clin.larvol.comTraffic data is only available for sites with a CashRank of $15 or better, an Alexa rank better than 100,000 or PageRank of 2 or more.If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt Similar Sitespegilodecakin (LY3500518) / Eli LillyNews for pegilodecakin (LY3500518) / Eli Lilly
LBL-007 / Leads Biolabs, BeiGeneNews for LBL-007 / Leads Biolabs, BeiGene
benmelstobart (APL-502) / Apollomics, Sino Biopharm, JSR Life SciencesNews for benmelstobart (APL-502) / Apollomics, Sino Biopharm, JSR Life Sciences
letetresgene autoleucel (GSK3377794) / AdaptimmuneNews for letetresgene autoleucel (GSK3377794) / Adaptimmune
More sites similar to ESMO 2021: [VIRTUAL] IMbrave150: Exploratory efficacy and safety resul... Find Another Website
|
Sponsored Results Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less
Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less |
Copyright (C) 2007 - 2024 Text Ad King and SecretSearchEngineLabs.com. All Rights Reserved.
Terms and Conditions - Privacy Policy - Advertising - About Us - Login